...
首页> 外文期刊>Journal of stroke and cerebrovascular diseases: The official journal of National Stroke Association >International Subarachnoid Aneurysm Trial (ISAT) of Neurosurgical Clipping Versus Endovascular Coiling in 2143 Patients with Ruptured Intracranial Aneurysms:A Randomized Trial
【24h】

International Subarachnoid Aneurysm Trial (ISAT) of Neurosurgical Clipping Versus Endovascular Coiling in 2143 Patients with Ruptured Intracranial Aneurysms:A Randomized Trial

机译:国际蛛网膜下腔动脉瘤试验对2143例颅内动脉瘤破裂的患者进行神经外科截断与血管内膜成形术的随机对照试验。

获取原文
获取原文并翻译 | 示例
           

摘要

Endovascular detachable coil treatment is being increasingly used as an alternative to craniotomy and clipping for some ruptured intracranial aneurysms, although the relative benefits of these two approaches have yet to be established. We undertook a randomized, multicenter trial to compare the safety and efficacy of endovascular coiling with standard neurosurgical clipping for such aneurysms judged to be suitable for both treatments. We enrolled 2143 patients with ruptured intracranial aneurysms and randomly assigned them to neurosurgical clipping (n=1070) or endovascular treatment by detachable platinum coils (n = 1073). Clinical outcomes were assessed at both 2 months and at 1 year with interim ascertainment of rebleeds and death. The primary outcome was the proportion of patients with a modified Rankin scale (mRs) score between 3 and 6 (dependency or death) at 1 year. Trial recruitment was stopped by the steering committee after a planned interim analysis. Analysis was per protocol. One hundred and ninety of 801 (23.7%) patients allocated endovascular treatment were dependent or dead at 1 year compared with 243 of 793 (30.6%) of those allocated neurosurgical treatment (P = .0019). The relative and absolute risk reductions in dependency or death after allocation to an endovascular versus neurosurgical treatment were 22.6% (95% CI 8.9-34.2) and 6.9% (2.5-11,3), respectively. The risk of rebleeding from the ruptured aneurysm after 1 year was two per 1276 and zero per 1081 patient-years for patients allocated endovascular and neurosurgical treatment, respectively. In patients with a ruptured intracranial aneurysm, for which endovascular coiling and neurosurgical clipping are therapeutic options, the outcome in terms of survival free of disability at 1 year is significantly better with endovascular coiling. The data available to date suggest that the long-term risks of further bleeding from the treated aneurysm are low with either therapy, although somewhat more frequent with endovascular coiling.
机译:血管内可分离线圈治疗正被越来越多地用作颅骨动脉瘤破裂的开颅手术和钳夹术的替代方法,尽管这两种方法的相对益处尚未确定。我们进行了一项随机的,多中心的试验,比较了对于这种被认为适合于两种治疗方法的动脉瘤,将血管内盘绕术与标准神经外科钳夹术的安全性和有效性进行比较。我们招募了2143例颅内动脉瘤破裂的患者,并将他们随机分配到神经外科钳夹术(n = 1070)或通过可拆卸的铂金线圈进行血管内治疗(n = 1073)。在2个月和1年时评估临床结局,同时确定出血和死亡。主要结局是在1年时兰金评分(mRs)评分在3到6(依赖性或死亡)之间的患者比例。经过计划的中期分析,指导委员会停止了试验招募。根据方案进行分析。接受血管内治疗的801名患者中有一百九十名(23.7%)在1年时是依赖或死亡,而接受神经外科治疗的793名患者中有243名(243.6%)死亡(P = .0019)。分配给血管内治疗与神经外科治疗相比,依从性或死亡的相对和绝对风险降低分别为22.6%(95%CI 8.9-34.2)和6.9%(2.5-11,3)。分配血管内和神经外科治疗的患者,一年后因动脉瘤破裂而再出血的风险分别为每1276个患者年两次和每1081个患者年零。对于颅内动脉瘤破裂的患者,血管内盘绕术和神经外科钳夹术是治疗选择,对于血管内盘绕术,在一年无残障生存率方面的结果明显更好。迄今可获得的数据表明,尽管采用血管内盘绕术的频率更高,但无论采用哪种疗法,经治疗的动脉瘤进一步出血的长期风险均较低。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号